On May 2, Axinn partner Chad Landmon spoke on, "Incentivizing Generic and Biosimilar Competition" at the FDLI Annual Conference in Washington, DC. This year’s conference explored advanced topics in food and drug law, focusing on complex legal, regulatory, compliance, and policy issues across FDA-regulated industries. 

Founded in 1949, the Food and Drug Law Institute (FDLI) is a nonprofit membership organization that offers education, training, publications, and professional engagement opportunities in the field of food and drug law.